Last updated: November 3, 2021
Sponsor: Foundation University Islamabad
Overall Status: Active - Recruiting
Phase
N/A
Condition
Scar Tissue
Treatment
N/AClinical Study ID
NCT05108272
FUI/CTR/2021/2
All Genders
Study Summary
Eligibility Criteria
Inclusion
- All the patients presenting with hypertrophic scars ≥1cm in size
- Any age
- Both genders
Exclusion
Exclusion criteria:
- Pregnant or lactating mothers
- Patients who already taking systemic steroid as confirmed through clinical record
- Patients with renal failure or liver failure as confirmed through clinical history
- Patient with uncontrolled diabetes.
- Patients who received treatment for keloids or hypertrophic scar in past.
- Patients with active inflammation in area of hypertrophic scar or in its vicinity.
Study Design
Total Participants: 80
Study Start date:
July 01, 2021
Estimated Completion Date:
March 30, 2022
Study Description
Connect with a study center
Foundation University Islamabad
Islamabad, Federal 46000
PakistanSite Not Available
FFH
Rawalpindi, Punjab
PakistanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.